Loading resource…

Thalassaemia International Federation
These guidelines provide comprehensive recommendations covering the genetic basis, pathophysiology, and diagnosis of both β‑ and α‑thalassaemia. They detail standards for blood transfusion practice, including haemovigilance, component specifications, transfusion thresholds, and management of adverse reactions. Iron overload assessment and therapy are addressed with evidence‑based recommendations. The document also outlines implementation strategies and levels of evidence for each recommendation. It is intended for clinicians managing transfusion‑dependent thalassaemia worldwide.
No account needed
Answers use this document only.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

SICKLECELL GUIDELINES 2025 (2)
Same clinical topic · Hematology

AMERICAN SOCIETY OF HEMATOLOGY 2026 GUIDELINES FOR DIAGNOSIS OF IRON DEFICIENCY
Same clinical topic · Hematology

Guideline for SCD Management - Uganda (2)
Same clinical topic · Hematology

SICKLECELL GUIDELINES 2025-2030
Same clinical topic · Hematology

AMERICAN SOCIETY OF HEMATOLOGY 2026 GUIDELINES FOR IMMUNE THROMBOCYTOPENIA (ITP): INITIAL AND SECOND-LINE THERAPY IN ADULTS WITH PRIMARY ITP
Same clinical topic · Hematology

AMERICAN SOCIETY OF HEMATOLOGY 2026 GUIDELINES FOR IMMUNE THROMBOCYTOPENIA (ITP): INITIAL AND SECOND-LINE THERAPY IN ADULTS WITH PRIMARY ITP
Same clinical topic · Hematology

AMERICAN SOCIETY OF HEMATOLOGY 2021 GUIDELINES FOR SICKLE CELL DISEASE: STEM CELL TRANSPLANTATION
Same clinical topic · Hematology

GUIDELINES FOR THE MANAGEMENT OF EMERGENCIES AND CRITICAL ILLNESS IN PEDIATRIC AND ADULT PATIENTS WITH SICKLE CELL DISEASE
Same clinical topic · Hematology

AMERICAN SOCIETY OF HEMATOLOGY 2021 GUIDELINES FOR MANAGEMENT OF VENOUS THROMBOEMBOLISM: PREVENTION AND TREATMENT IN PATIENTS WITH CANCER
Same clinical topic · Hematology